Artelo biosciences to present at microcap rodeo's spring into action best ideas virtual conference on may 16th

Solana beach, ca / accesswire / may 13, 2022 / artelo biosciences, inc. "artelo" or the "company") (nasdaq:artl), a clinical stage pharmaceutical company developing therapeutics that modulate lipid-signaling pathways, including the endocannabinoid system, today announced that gregory d. gorgas, chief executive officer of artelo has been invited to present at the spring into action - best ideas virtual investor conference, which is being held virtually may 16th - 20th, 2022.
ARTL Ratings Summary
ARTL Quant Ranking